Patents-Review.com
ClassID:

96526 ⎘

C07J21/00 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton

Sub-classes:
Recent Application in this class:
#1
20260116912
2026-04-30

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #2
20260116911
2026-04-30

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #3
20260034146
2026-02-05

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #4
20250319106
2025-10-16

19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF

 #5
20250206774
2025-06-26

C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS

 #6
20240409576
2024-12-12

-ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions-

 #7
20240368213
2024-11-07

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

 #8
20240317795
2024-09-26

HALOGENATED CHOLESTEROL ANALOGUES AND METHODS OF MAKING AND USING SAME

 #9
20240239836
2024-07-18

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

 #10
20230391816
2023-12-07

NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF

 #11
20230279044
2023-09-07

Neuroactive steroids, compositions, and uses thereof

 #12
20230190770
2023-06-22

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #13
20230113666
2023-04-13

Compositions and methods for treating CNS disorders

 #14
20220220150
2022-07-14

Compositions and methods for treating CNS disorders

 #15
20220110950
2022-04-14

19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof

 #16
20210403502
2021-12-30

Neuroactive steroids, compositions, and uses thereof

 #17
20210379084
2021-12-09

INHIBITORS OF GLUCOCORTICOID RECEPTOR

 #18
20210355154
2021-11-18

Halogenated Cholesterol Analogues and Methods of Making and Using Same

 #19
20210308149
2021-10-07

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #20
20210139531
2021-05-13

19-nor neuroactive steroids and methods of use thereof

 #21
20210094981
2021-04-01

Neuroactive steroids, compositions, and uses thereof

 #22
20210061848
2021-03-04

Neuroactive steroids, compositions, and uses thereof

 #23
20210023095
2021-01-28

Inhibitors of glucocorticoid receptor

 #24
20200392177
2020-12-17

Compositions and methods for treating CNS disorders

 #25
20200155576
2020-05-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #26
20200113916
2020-04-16

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #27
20200048300
2020-02-13

19-NOR neuroactive steroids and methods of use thereof

 #28
20200016178
2020-01-16

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #29
20190211054
2019-07-11

19-NOR NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF

 #30
20190177358
2019-06-13

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

 #31
20190169226
2019-06-06

Neuroactive steroids, compositions, and uses thereof

 #32
20190112331
2019-04-18

19-nor neuroactive steroids and methods of use thereof

 #33
20180311262
2018-11-01

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #34
20180265540
2018-09-20

SYNTHESIS OF ESTETROL VIA ESTRONE DERIVED STEROIDS

 #35
20180258133
2018-09-13

MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA

 #36
20180155386
2018-06-07

PROGESTERONE ANTAGONISTS

 #37
20180141971
2018-05-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #38
20180051052
2018-02-22

19-nor neuroactive steroids and methods of use thereof

 #39
20170267712
2017-09-21

MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA

 #40
20170247406
2017-08-31

Neuroactive steroids, compositions, and uses thereof

 #41
20170246191
2017-08-31

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #42
20170240589
2017-08-24

Compositions and methods for treating CNS disorders

 #43
20170190732
2017-07-06

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #44
20170152282
2017-06-01

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #45
20160251391
2016-09-01

Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors

 #46
20160244478
2016-08-25

Method for preparing 6-alkylated steroidal derivatives and corresponding alkylated 5,6,7,8-tetrahydronaphthalene-2(4 alpha.H)-ones

 #47
20160168190
2016-06-16

C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS

 #48
20160159852
2016-06-09

Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer

 #49
20160108080
2016-04-21

19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

 #50
20160083417
2016-03-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

 #51
20160060289
2016-03-03

Non-hormonal steroid modulators of NF-κB for treatment of disease

 #52
20150376225
2015-12-31

NOVEL COMPOUNDS OF 11BETA-HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION OR DEPLETION

 #53
20150315230
2015-11-05

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

 #54
20150140088
2015-05-21

SPIROSTEROID SYSTEMS ACTING AS NEUROPROTECTIVE AND ANTI-INFLAMMATORY AGENTS

 #55
20150105362
2015-04-16

Synthesis of estetrol via estrone derived steroids

 #56
20140364600
2014-12-11

Imidazolyl progesterone antagonists

 #57
20140357868
2014-12-04

Methods for stereoselective reduction

 #58
20140235600
2014-08-21

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

 #59
20140088053
2014-03-27

Inhibitors of 17β-HSD1, 17β-HSD3 and 17β-HSD10

 #60
20140056916
2014-02-27

Aldosterone induced vascular elastin production

 #61
20130295117
2013-11-07

Composition for elastin production

 #62
20130196962
2013-08-01

Non-hormonal steroid modulators of NF-κB for treatment of disease

 #63
20130150333
2013-06-13

Modulators of retinoid-related orphan receptor gamma

 #64
20130029953
2013-01-31

PROGESTERONE ANTAGONISTS

 #65
20120195914
2012-08-02

Deoxycorticosterone induced elastin production

 #66
20110165176
2011-07-07

Aldosterone induced vascular elastin production

 #67
20110160457
2011-06-30

Methods for obtaining cyclopamine

 #68
20110028711
2011-02-03

Unsaturated Steroid Compounds

 #69
20110009442
2011-01-13

Methods for stereoselective reduction

 #70
20100331269
2010-12-30

TRITERPENES DERIVATIVES AND USES THEREOF AS ANTITUMOR AGENTS OR ANTI-INFLAMMATORY AGENTS

 #71
20100317632
2010-12-16

17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative

 #72
20100273759
2010-10-28

Progesterone antagonists

 #73
20100234335
2010-09-16

Neurosteroid compounds

 #74
20100137264
2010-06-03

Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones

 #75
20090259038
2009-10-15

PROCESS FOR PRODUCING (5ALPHA7ALPHA)-3-SPIRO-2'-(1',3'-DIOXOLAN)-24-OXOCHOLEST-22-EN-7-YL BENZOATE

 #76
20090181936
2009-07-16

Diene and triene compounds and formulations

 #77
20090176752
2009-07-09

Diene compounds and formulations

 #78
20090041779
2009-02-12

Aldosterone induced elastin production

 #79
20090029953
2009-01-29

18-METHYL-19-NOR-17-PREGN-4-ENE-21,17-CARBOLACTONES, AS WELL AS PHARMACEUTICAL PREPARATIONS THAT CONTAIN THE LATTER

 #80
20080261935
2008-10-23

2″ oxo-voruscharin and derivatives thereof

 #81
20080234478
2008-09-25

Process for the preparation and purification of eplerenone

 #82
20080200733
2008-08-21

Processes For The Preparation Of Purified Solanesol, Solanesyl Bromide & Solanesyl Acetone

 #83
20080167254
2008-07-10

TRITERPENES DERIVATIVES AND USES THEREOF AS ANTITUMOR AGENTS OR ANTI-INFLAMMATORY AGENTS

 #84
20080070881
2008-03-20

Prostate cancer treatment

 #85
20080027237
2008-01-31

Processes for preparations of 9,11-epoxy steroids and intermediates useful therein

 #86
20080009472
2008-01-10

Prostate cancer treatment

 #87
20080004250
2008-01-03

Steroids having 1,8-unsaturation and formulations comprising same

 #88
20070249573
2007-10-25

17alpha-substituted 4-(3-oxoestra-4,9-dien-11beta-yl)-benzoic acid, its derivatives and process for its production

 #89
20070129332
2007-06-07

Processes to prepare eplerenone

 #90
20070123704
2007-05-31

7α-biscarbonyl-substituted steroid compounds

 #91
20070117780
2007-05-24

7α-Hydroxyacetyl and 7α-Hydroperoxyacetyl-substituted steroid compounds

 #92
20070106072
2007-05-10

7a-Furyl or thienyl-substituted steroid compounds

 #93
20070100140
2007-05-03

7 α-Enedione-substituted steroid compounds

 #94
20070066580
2007-03-22

Novel aldosterone antagonists and uses thereof

 #95
20070066579
2007-03-22

5-androsten-3beta-ol steroid intermediates and processs for their preparation

 #96
20070060746
2007-03-15

PROCESSES FOR PREPARATION OF 9,11 EPOXY STEROIDS AND INTERMEDIATES USEFUL THEREIN

 #97
20070004689
2007-01-04

Antiangiogenic agents

 #98
20060258857
2006-11-16

Process for making steroidal compounds

 #99
20060247216
2006-11-02

Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments

 #100
20060211669
2006-09-21

Synthesis of estetrol via estrone derived steroids

 #101
20060166952
2006-07-27

2″ oxo-voruscharin and derivatives thereof

 #102
20060111577
2006-05-25

Method for preparing 17 alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates

 #103
20060111332
2006-05-25

Process and intermediates to prepare17beta-hydroxy-7alpha-methyl-19-nor-17alpha-pregn -5(10)-en-20-yn-3-one

 #104
20060100185
2006-05-11

5-Androsten-3beta-ol steroid intermediates and processes for their preparation

 #105
20050272927
2005-12-08

Process for the preparation of 9, 11 epoxy steroids

 #106
20050267302
2005-12-01

Eplerenone crystalline form exhibiting enhanced dissolution rate

 #107
20050256094
2005-11-17

Processes for preparation of 9,11-epoxy steroids and intermediates useful therein

 #108
20050239761
2005-10-27

Keto-substituted steroid compounds

 #109
20050159594
2005-07-21

Eplerenone crystal form exhibiting enhanced dissolution rate